Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma
Clinical trial NCT02426229 · COMPLETED
Trial details
- NCT number
- NCT02426229
- Sponsor
- Medical University of South Carolina
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2018-06-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.